Is NCT07197762 recruiting in Atlanta, GA?

Yes, NCT07197762 is currently recruiting participants at its Atlanta, GA location. This meningitis clinical trial is actively enrolling qualified participants.

How do I join the meningitis clinical trial in Atlanta?

To join this clinical trial in Atlanta, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Atlanta clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Meningitis Clinical Trial in Atlanta, GA

About This Meningitis Study in Atlanta

The goal of this clinical trial is to determine the immunogenicity of certain vaccines in protecting against meningitis B (MenB) in young adults who have previously received a different MenB vaccine. The main questions it aims to answer are: * How many participants are protected against four key types of MenB bacteria before and after getting the new vaccine? * How strong is the immune response after vaccination, and how many people show a noticeable boost in immune response?

Sponsor: Emory University

Who Can Participate

Inclusion Criteria

Provides written informed consent before any study procedures are performed.

Be able to understand and agree to comply with planned study procedures and be available for all study visits.

Subject is in good health as determined by vital signs, medical history, targeted physical examination (if indicated), and the judgment of the investigator.

Vaccinated with 2-dose Bexsero primary series at least 2.5 years before vaccination. Must confirm vaccination status and dates of administration through GRITS, healthcare provider, or other official documentation

Women of childbearing potential must agree to use or have practiced true abstinence2 or use at least one acceptable primary form of contraception from 28 days prior through 28 days after vaccination.

Women of childbearing potential must have a negative urine or serum pregnancy test within 24 hours before vaccination

Exclusion Criteria

Subject has an acute illness with fever (temperature ≥100.4 °F) within 72 hours before vaccine administration.

Subject is currently pregnant or breastfeeding an infant/child.

Has any medical disease or condition that, in the opinion of the site PI or appropriate sub-investigator, precludes study participation. (Including acute, subacute, intermittent,t or chronic medical disease or condition that would place the subject at an unacceptable risk of injury, render the subject unable to meet the requirements of the protocol, or may interfere with the evaluation of responses or the subject's successful completion of this trial. Chronic medical conditions that are stable, with no escalation in medication doses or new medications administered in the preceding 3 months, will not be considered exclusionary.)

Presence of self-reported or medically documented significant medical or psychiatric condition(s) as determined by the investigator.

Received or plans to receive a licensed, live vaccine within 4 weeks before or after the study vaccination.

Received or plans to receive a licensed, inactivated vaccine within 2 weeks before through 4 weeks after the study vaccination.

Any previous severe hypersensitivity or anaphylactic reaction to any vaccine or vaccine-related component

Bleeding diathesis or condition associated with prolonged bleeding time that would contraindicate intramuscular injection.

Received any MenB vaccine within the last 2.5 years before vaccination.

Received more than 2 doses of Bexsero or any other MenB vaccine(s) (e.g. Trumenba or Penbraya)

Any known or suspected defect of the immune system that would prevent an immune response to the vaccine, such as participants with congenital or acquired defects in B-cell function, those receiving chronic systemic (oral, intravenous, or intramuscular) corticosteroid therapy \>20 mg per day for ≥14 days, or those receiving immunosuppressive therapy. Participants with terminal complement deficiency are excluded from participation in this study.

Significant neurological disorder or history of seizure (excluding simple febrile seizure).

Any neuroinflammatory condition or autoimmune condition requiring immunomodulatory treatment, including, but not limited to, Guillain-Barré syndrome, transverse myelitis, uveitis, optic neuritis, and multiple sclerosis.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT07197762) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Meningitis Treatment Options in Atlanta, GA

If you're searching for meningitis treatment options in Atlanta, GA, this clinical trial (NCT07197762) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced meningitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all meningitis clinical trials near you to find additional studies recruiting in your area.

Meningitis Clinical Trial in Atlanta, GA

Expert Care in Atlanta

IRB Approved

No-Cost Care

Apply for This Atlanta Location

Why Participate?

Simple Process